[HTML] thelancet.com

[HTML][HTML] 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial

NV Joshi, AT Vesey, MC Williams, ASV Shah… - The Lancet, 2014 - thelancet.com
Background The use of non-invasive imaging to identify ruptured or high-risk coronary
atherosclerotic plaques would represent a major clinical advance for prevention and …
被引用次数：1035 相关文章

18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial

NV Joshi, AT Vesey, MC Williams, ASV Shah… - The Lancet, 2014 - infona.pl
The use of non-invasive imaging to identify ruptured or high-risk coronary atherosclerotic
plaques would represent a major clinical advance for prevention and treatment of coronary …
[HTML] thelancet.com

[HTML][HTML] 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial

NV Joshi, AT Vesey, MC Williams, ASV Shah… - The Lancet, 2014 - thelancet.com
Background The use of non-invasive imaging to identify ruptured or high-risk coronary
atherosclerotic plaques would represent a major clinical advance for prevention and …

[引用][C] 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial

NV JOSHI, AT VESEY, EJR VAN BEEK… - Lancet (British …, 2014 - pascal-francis.inist.fr
Author JOSHI, Nikhil V 1; VESEY, Alex T 1; VAN BEEK, Edwin J. R 1; FLAPAN, Andrew D 2;
UREN, Neal G 2; BEHAN, Miles W. H 2; CRUDEN, Nicholas L. M 2; MILLS, Nicholas L 1; …
[PDF] researchgate.net

[PDF][PDF] ¹⁸F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial

NV Joshi, AT Vesey, MC Williams, ASV Shah… - 2013 - researchgate.net
Background The use of non-invasive imaging to identify ruptured or high-risk coronary
atherosclerotic plaques would represent a major clinical advance for prevention and …

18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial

NV Joshi, AT Vesey, MC Williams… - Lancet (London …, 2014 - pubmed.ncbi.nlm.nih.gov
Background The use of non-invasive imaging to identify ruptured or high-risk coronary
atherosclerotic plaques would represent a major clinical advance for prevention and …
[PDF] ed.ac.uk

[PDF][PDF] ¹⁸F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial

NV Joshi, AT Vesey, MC Williams, ASV Shah… - 2013 - pure.ed.ac.uk
Background The use of non-invasive imaging to identify ruptured or high-risk coronary
atherosclerotic plaques would represent a major clinical advance for prevention and …

[引用][C] 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial

NV Joshi, AT Vesey, MC Williams, ASV Shah… - The Lancet, 2014 - cir.nii.ac.jp
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary
atherosclerotic plaques: a prospective clinical trial | CiNii Research CiNii 国立情報学研究所 学術 …

18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.

NV Joshi, AT Vesey, MC Williams, AS Shah… - Lancet (London …, 2013 - europepmc.org
Background The use of non-invasive imaging to identify ruptured or high-risk coronary
atherosclerotic plaques would represent a major clinical advance for prevention and …
[PDF] academia.edu

[PDF][PDF] ¹⁸F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial

NV Joshi, AT Vesey, MC Williams, ASV Shah… - 2013 - academia.edu
Background The use of non-invasive imaging to identify ruptured or high-risk coronary
atherosclerotic plaques would represent a major clinical advance for prevention and …